Michael Smith

Michael Smith is currently the Director of Quality Science & Strategy at AstraZeneca, where they support engagement and understanding of regulatory compliance in GxP activities. They have extensive international experience in quality assurance and management, with a focus on improving the audit and quality management processes within clinical trials. Previously, Michael held various senior roles at companies such as Schering, PPD, and Merck KGaA, contributing to strategic quality oversight, operational quality control, and vendor quality management. Michael's background includes significant expertise in Good Clinical Practice and corrective action processes, as well as a history of leadership in both matrix and line management structures.